Research Plan of the Department of Pharmacology and Toxicology at the College of Pharmacy, UQU
The Department of Pharmacology and Toxicology at the College of Pharmacy, UQU aims to:
1. Achieving applied research excellence with direct return on development and community service plans represented in the international publication, innovations, patents, etc.
2. Cooperation and integration between the various scientific departments of the College by encouraging collective researches with common disciplines, which help raise the academic and research efficiency of staff members.
3. Encouraging staff members to develop research projects in collaboration with the research bodies (ISR-DSR) through advanced technology to meet research needs.
4. Encouraging, employing the outputs of, benefiting from and marketing priority research projects for the Saudi society.
Values Governing Scientific Research (Scientific Research Ethics):
• Scientific honesty.
• Credibility and transparency.
• Excellence and innovation.
• Protection of intellectual property.
Main Domains of UQU Pharmacology and Toxicology Department Research Plan:
1st Domain: Study of some natural compounds' effects:
It includes the study of the effect of certain natural compounds such as herbs in the treatment of some chronic diseases prevalent in the Saudi society. This is achieved by studying the effect of some plant extracts on harmful environmental substances, such as chemicals and pesticides, which cause liver, kidney, and cancer diseases for instance. The first domain also involves studying some of the effects of such herbal plants and the extent to which they contain antioxidants, anti-inflammation and anti-infection, as well as their effect on experimental animals.
2nd Domain: Unusual uses of certain pharmaceuticals:
It includes the use of pharmaceuticals that treat some common diseases nontraditionally. This aims either to discover new ways to cure or reduce the usual side effects, unveil new pharmaceuticals for some difficult-to-treat diseases such as cancer tumors and hepatitis C.
3rd Domain: Production of new compounds from natural sources and assistance of pharmaceutical companies in the evaluation of effective natural substances to treat certain diseases.
This includes the separation, identification of the chemical composition, and development of some derivatives of natural products, as well as the study of their biological effects and medical benefits in the treatment of some diseases. The third domain also comprises the development of some modern methods of quantitative evaluation of the active substances in plants and pharmaceuticals, which are traded on the markets. Moreover, it involves the use of Plant Tissue Culture of medicinal plants under different conditions to increase the productivity of active substances.
4th Domain: Searching for the most significant medical and health problems and methods to overcome them:
It includes studying common diseases in the Saudi society such as obesity, heart diseases, diabetes, etc., and trying to find a cure for them. In addition, it involves the study of some certain compounds that are likely to have an effect, such as antimicrobials, viruses and tumors, and the use of nanoparticles in the treatment of microbiological infections. This domain also deals with the study of mutations arising from the hepatitis virus.